PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsThymalfasin
Thymalfasin
Thymalfasin is a protein pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
57 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HepatitisD006505K75.91427
Hepatitis aD006506EFO_0007305B151427
Hepatitis bD00650912136
Chronic hepatitis bD019694EFO_0004239B18.112125
CarcinomaD002277C80.012114
SepsisD018805EFO_0001420A41.91124
ToxemiaD0141151113
Hepatocellular carcinomaD006528C22.0112
Liver neoplasmsD008113EFO_1001513C22.0112
Liver cirrhosisD008103EFO_0001422K74.022
Show 9 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD0151792114
Covid-19D000086382U07.11214
Hepatitis cD006526B19.233
Chronic hepatitis cD019698EFO_0004220B18.233
Coronavirus infectionsD018352EFO_0007224B34.211
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lung neoplasmsD008175C34.901729
Non-small-cell lung carcinomaD0022891527
Small cell lung carcinomaD055752133
NeoplasmsD009369C80133
AdenocarcinomaD00023022
RadiotherapyD01187822
Hematologic neoplasmsD019337122
PneumoniaD011014EFO_0003106J1811
Adenocarcinoma of lungD00007719211
MelanomaD00854511
Show 10 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B2022
InfectionsD007239EFO_000054411
Hiv seropositivityD00667911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Aortic dissectionD000784I71.022
Liver failureD017093K72.911
Hepatic insufficiencyD04855011
Acute aortic syndromeD00009468311
Cardiopulmonary bypassD00231511
Heart diseasesD006331EFO_0003777I51.911
Rheumatic heart diseaseD012214EFO_1001161I09.911
ImmunotherapyD00716711
Rheumatic diseasesD012216M79.011
Squamous cell carcinomaD00229411
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameThymalfasin
INNthymalfasin
Description
THYMALFASIN
Classification
Protein
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
Identifiers
PDB
CAS-ID62304-98-7
RxCUI
ChEMBL IDCHEMBL2103979
ChEBI ID
PubChem CID
DrugBank
UNII IDW0B22ISQ1C (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,097 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
43 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use